Thameus is specialising in newborn screening (NBS) using next-generation DNA sequencing (NGS).
About
Thameus is a spinoff from the CHU of the University of Liège, working closely with the research team behind Baby Detect, a neonatal screening test that detects treatable diseases using just a few drops of blood.
We are eager to exchange insights and experiences with other IVD companies active in screening and/or DNA sequencing.
We are eager to exchange insights and experiences with other IVD companies active in screening and/or DNA sequencing.